United States · FDA National Drug Code directory

Levothyroxine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82804-099_9e69af45-d5a3-4986-8ea5-dee9e59272d7
Product NDC
82804-099
Form
TABLET
Composition / generic term
Levothyroxine Sodium
Labeler
Proficient Rx LP
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20200803
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — 50 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (82804-099-30) · 82804-099-30
  • 90 TABLET in 1 BOTTLE (82804-099-90) · 82804-099-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Levothyroxine Sodium — United States | Molindra Medicines